Johnson & Johnson (JNJ) Company Description: Johnson & Johnson provides healthcare products across three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women’s health, and wou...
Johnson & Johnson (J&J) researches, develops, manufactures, and sells pharmaceutical products and medical devices. The company conducts business through its operating companies. It provides pharmaceuticals for immune disorders, cancer, neurological disorders, infectious, cardiovascular, and metabolic diseases;...
Company Research Report: Johnson & Johnson. Company details, financials, key personnel, industries of involvement, service providers and more. Download instantly.
Providing personal information to us through the Careers Sites or to our Talent Acquisition specialists is voluntary, but necessary for the recruiting process. Consistent with applicable law, if you do not provide sufficient information, theJohnson & Johnsoncompany considering you for the hiring process...
In light of Coronavirus, Johnson & Johnson is expected to perform above industry average in 2020, boosted by the successes of its analgesics and cough, cold...
The article profiles personal care company Johnson and Johnsons. It is reported that the company has a total earnings of 3.45 billion dollars for the second quarter of 2010 compared to 3.21 billion in second quarter of 2009. Company's description is also offered, its business operation, ...
Shareholders, employees and others may contact the Board of Directors of Johnson & Johnson, its Lead Director (who is independent and not an employee of the Company) or a member of the Audit Committee through any of the means below. Employees and others who wish to contact the Board or ...
and uncertainties that may cause the company's actual results to differ materially from those projected. A description of these risks, uncertainties, and other factors can be found in our SEC filings, including our 2023 Form 10-K, which is available at investor.jnj.com and on the SEC's ...
and uncertainties that may cause the company's actual results to differ materially from those projected. A description of these risks, uncertainties, and other factors can be found in our SEC filings, including our 2023 Form 10-K, which is available at investor.jnj.com and on the SEC's ...
(Nasdaq: ITCI) announced today that they have entered into a definitive agreement under whichJohnson & Johnsonwill acquire all outstanding shares ofIntra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) ...